Community-acquired pneumonia and the role of levofloxacin in its management New drugs and disease management 12 February 2013 Pages: 1 - 5
Immediate identification and management of anthrax essential for optimal outcome New drugs and disease management 12 February 2013 Pages: 6 - 11
The HMG-CoA reductase inhibitors — new safety concerns? Drug reactions and interactions 12 February 2013 Pages: 11 - 15
First reports of adverse drug reactions (ADRs) in recent weeks Drug reactions and interactions 12 February 2013 Pages: 15 - 15